Share Price
Latest News
-
FDA grants New Chemical Entity designation for XENOVIEW
01 February 2023
-
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized)
28 December 2022 -
Update on New Drug Application
30 September 2022
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts